Mirjam Mol-Arts

1.3k total citations
8 papers, 796 citations indexed

About

Mirjam Mol-Arts is a scholar working on Genetics, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mirjam Mol-Arts has authored 8 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Oncology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mirjam Mol-Arts's work include Estrogen and related hormone effects (7 papers), Cancer Risks and Factors (4 papers) and Breast Cancer Treatment Studies (3 papers). Mirjam Mol-Arts is often cited by papers focused on Estrogen and related hormone effects (7 papers), Cancer Risks and Factors (4 papers) and Breast Cancer Treatment Studies (3 papers). Mirjam Mol-Arts collaborates with scholars based in Netherlands, Austria and United Kingdom. Mirjam Mol-Arts's co-authors include Peter Kenemans, Bo von Schoultz, E. Kubista, P Sismondi, N.J. Bundred, Wendy M. Kersemaekers, Gunnar Söderqvist, Susan R. Johnson, Wilfried Seifert and R. J. Mulder and has published in prestigious journals such as New England Journal of Medicine, The Lancet Oncology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Mirjam Mol-Arts

8 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mirjam Mol-Arts Netherlands	8	536	453	340	170	123	8	796
R. Don Gambrell United States	19	624 1.2×	487 1.1×	222 0.7×	141 0.8×	77 0.6×	39	971
R. Nachtigall United States	7	401 0.7×	382 0.8×	133 0.4×	117 0.7×	23 0.2×	11	673
K.-D. Schulz Germany	15	170 0.3×	137 0.3×	160 0.5×	88 0.5×	111 0.9×	31	634
Valentina Elisabetta Bounous Italy	18	176 0.3×	199 0.4×	278 0.8×	156 0.9×	176 1.4×	43	858
Leilani Morales Belgium	6	246 0.5×	94 0.2×	222 0.7×	30 0.2×	68 0.6×	10	388
Merja B. Marttunen Finland	8	191 0.4×	77 0.2×	124 0.4×	27 0.2×	54 0.4×	9	389
P Stattin Sweden	7	85 0.2×	215 0.5×	200 0.6×	29 0.2×	70 0.6×	7	560
Usha Sriram India	8	166 0.3×	107 0.2×	170 0.5×	38 0.2×	33 0.3×	13	435
Helge Bennmarker Sweden	8	176 0.3×	621 1.4×	65 0.2×	40 0.2×	30 0.2×	9	778
Marta D’Alonzo Italy	10	138 0.3×	106 0.2×	150 0.4×	133 0.8×	186 1.5×	25	545

Countries citing papers authored by Mirjam Mol-Arts

Since Specialization

Citations

This map shows the geographic impact of Mirjam Mol-Arts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam Mol-Arts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam Mol-Arts more than expected).

Fields of papers citing papers by Mirjam Mol-Arts

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam Mol-Arts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam Mol-Arts. The network helps show where Mirjam Mol-Arts may publish in the future.

Co-authorship network of co-authors of Mirjam Mol-Arts

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam Mol-Arts. A scholar is included among the top collaborators of Mirjam Mol-Arts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam Mol-Arts. Mirjam Mol-Arts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Bundred, Nigel, Peter Kenemans, Cheng Har Yip, et al.. (2012). Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy. Breast Cancer Research. 14(1). R13–R13. 27 indexed citations

Sismondi, P, Rainer Kimmig, E. Kubista, et al.. (2011). Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients—Data from LIBERATE trial. Maturitas. 70(4). 365–372. 33 indexed citations

Kenemans, Peter, N.J. Bundred, Jean-Michel Foidart, et al.. (2009). Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. The Lancet Oncology. 10(2). 135–146. 205 indexed citations

Ettinger, Bruce, Peter Kenemans, Susan R. Johnson, et al.. (2008). Endometrial Effects of Tibolone in Elderly, Osteoporotic Women. Obstetrics and Gynecology. 112(3). 653–659. 17 indexed citations

Cummings, Steven R., Bruce Ettinger, Pierre D. Delmas, et al.. (2008). The Effects of Tibolone in Older Postmenopausal Women. New England Journal of Medicine. 359(7). 697–708. 292 indexed citations

Kroiss, Regina, IS Fentiman, F.A. Helmond, et al.. (2005). The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double‐blind, placebo‐controlled trial. BJOG An International Journal of Obstetrics & Gynaecology. 112(2). 228–233. 39 indexed citations

Conner, Peter, Wendy M. Kersemaekers, Gunnar Söderqvist, et al.. (2004). A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen–progestogen treatment. Climacteric. 7(1). 50–58. 46 indexed citations

Lundström, Eva, Wendy M. Kersemaekers, Gunilla Svane, et al.. (2002). Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. American Journal of Obstetrics and Gynecology. 186(4). 717–722. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact